We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
26
Adobe
ADBE
$109B
$13.7M 0.47%
24,673
-174
-0.7% -$84.3K
PEP icon
27
PepsiCo
PEP
$188B
$13.5M 0.46%
81,803
-3,082
-4% -$532K
XOM icon
28
ExxonMobil
XOM
$657B
$13.2M 0.45%
114,315
+3,722
+3% +$433K
VNQ icon
29
Vanguard Real Estate ETF
VNQ
$38.6B
$13.1M 0.45%
156,586
+2,824
+2% +$233K
QCOM icon
30
Qualcomm
QCOM
$170B
$13M 0.45%
65,282
-183
-0.3% -$34.6K
BRK.B icon
31
Berkshire Hathaway Class B
BRK.B
$1.13T
$13M 0.44%
31,834
-699
-2% -$286K
CSCO icon
32
Cisco
CSCO
$483B
$11.3M 0.39%
238,281
-696
-0.3% -$33K
SDY icon
33
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$11M 0.38%
86,507
+3,768
+5% +$485K
YLD icon
34
Principal Active High Yield ETF
YLD
$582M
$10.8M 0.37%
565,975
+41,644
+8% +$790K
ISRG icon
35
Intuitive Surgical
ISRG
$139B
$10.5M 0.36%
23,526
-39
-0.2% -$15.5K
VWO icon
36
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$10.3M 0.35%
235,735
-35,331
-13% -$1.52M
UNH icon
37
UnitedHealth
UNH
$371B
$10.3M 0.35%
20,132
-246
-1% -$121K
V icon
38
Visa
V
$675B
$9.99M 0.34%
38,067
-240
-0.6% -$65.8K
ABBV icon
39
AbbVie
ABBV
$438B
$9.96M 0.34%
58,088
-36
-0.1% -$5.96K
CVX icon
40
Chevron
CVX
$382B
$9.81M 0.34%
62,693
-209
-0.3% -$33.3K
SPY icon
41
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$9.78M 0.34%
17,967
-4,467
-20% -$2.34M
PG icon
42
Procter & Gamble
PG
$340B
$9.25M 0.32%
56,081
+764
+1% +$125K
HD icon
43
Home Depot
HD
$350B
$8.72M 0.3%
25,338
-164
-0.6% -$55.9K
BIV icon
44
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$8.53M 0.29%
113,935
+4,393
+4% +$326K
LIN icon
45
Linde
LIN
$227B
$8.44M 0.29%
19,245
-185
-1% -$81.4K
HON icon
46
Honeywell
HON
$77B
$8.18M 0.28%
40,621
-399
-1% -$75.9K
AMAT icon
47
Applied Materials
AMAT
$415B
$7.77M 0.27%
32,921
-292
-0.9% -$62.7K
VRTX icon
48
Vertex Pharmaceuticals
VRTX
$133B
$7.71M 0.26%
16,446
-63
-0.4% -$27.3K
MRK icon
49
Merck
MRK
$323B
$7.3M 0.25%
58,964
-5,097
-8% -$657K
INTU icon
50
Intuit
INTU
$91.5B
$7.29M 0.25%
11,090
-82
-0.7% -$50.9K

Similar funds

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.